Search results for "TREATMENT"

showing 10 items of 17623 documents

Awareness and understanding of cancer immunotherapy in Europe.

2014

3053 Background: Use of immunotherapies in the treatment of cancer is growing and a range of new immunotherapeutic strategies are being evaluated. It is important that healthcare providers (HCP) understand these treatments and how they compare with and may complement established therapies. As part of the activities of the POINT expert group, we commissioned a survey of current awareness, attitudes and perceptions of cancer immunotherapy in Europe. Methods: From August-September 2011, 426 healthcare professionals (HCPs: oncologists, surgeons and oncology nurses) from France, Germany, Italy, Spain and the UK (~85 respondents/country) completed online interviews. Representatives of patient ad…

Health Knowledge Attitudes PracticeCancer Researchmedicine.medical_specialtyPathologyHealth Personnelmedicine.medical_treatmentImmunologyeducationAlternative medicineProfessional CompetenceCancer immunotherapyNeoplasmsmedicineImmunology and AllergyHumansFormularyIntensive care medicinePharmacologyHealth professionalsbusiness.industryData CollectionCancerImmunotherapymedicine.diseaseClinical trialEuropeTolerabilityOncologyFamily medicineUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]ImmunotherapybusinessHealthcare providersResearch PaperJournal of Clinical Oncology
researchProduct

Identification of Plakortide E from the Caribbean Sponge Plakortis halichondroides as a Trypanocidal Protease Inhibitor using Bioactivity-Guided Frac…

2014

In this paper, we report new protease inhibitory activity of plakortide E towards cathepsins and cathepsin-like parasitic proteases. We further report on its anti-parasitic activity against Trypanosoma brucei with an IC50 value of 5 mu M and without cytotoxic effects against J774.1 macrophages at 100 mu M concentration. Plakortide E was isolated from the sponge Plakortis halichondroides using enzyme assay-guided fractionation and identified by NMR spectroscopy and mass spectrometry. Furthermore, enzyme kinetic studies confirmed plakortide E as a non-competitive, slowly-binding, reversible inhibitor of rhodesain.

ProteasesStereochemistrymedicine.medical_treatmentTrypanosoma brucei bruceiPlakortis halichondroidesPharmaceutical ScienceTrypanosoma brucei01 natural sciences570 Life sciencesDioxanesprotease inhibitor03 medical and health sciencesddc:593Drug DiscoverymedicineAnimalsHumansProtease Inhibitorscathepsinlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)IC50030304 developmental biologyTrypanocidal agentrhodesainchemistry.chemical_classification0303 health sciencesProteaseAntiparasitic Agentsbiology010405 organic chemistryCommunicationplakortide Ebiology.organism_classificationCathepsinsTrypanocidal AgentsAntiparasitic agentProtease inhibitor (biology)Porifera0104 chemical sciencesCysteine Endopeptidasesslowly-binding reversible inhibitorEnzymelcsh:Biology (General)BiochemistrychemistryDrug Screening Assays Antitumor570 Biowissenschaftenmedicine.drug
researchProduct

Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety,…

2011

Intensive research is devoted to unravel the neurobiological mechanisms mediating adult hippocampal neurogenesis, its regulation by antidepressants, and its behavioral consequences. Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine that is expressed in the CNS, where its function is unknown. Here, we show, for the first time, the relevance of MIF expression for adult hippocampal neurogenesis. We identify MIF expression in neurogenic cells (in stem cells, cells undergoing proliferation, and in newly proliferated cells undergoing maturation) in the subgranular zone of the rodent dentate gyrus. A causal function for MIF in cell proliferation was shown using genetic (M…

Receptors SteroidStem-Cellsanimal diseasesmedicine.medical_treatmentHippocampusExpressionHippocampal formationHippocampusSubgranular zonememoryMice0302 clinical medicineConditioning PsychologicalCyclin D2Rat Dentate GyrusMice KnockoutNeurons0303 health sciencesMicroscopy ConfocalChronic StressMifNeurogenesisBrainFearrespiratory systemanxietyPsychiatry and Mental healthC-Reactive ProteinCytokinemedicine.anatomical_structuredepressionAntidepressive Agents Second-GenerationStem cellPsychologyAnimal-ModelNeurogenesisSpatial BehaviorNerve Tissue Proteinschemical and pharmacologic phenomena03 medical and health sciencesCellular and Molecular Neurosciencemedicineotorhinolaryngologic diseasesAnimalsRats WistarMaze LearningMacrophage Migration-Inhibitory FactorsMolecular BiologyCell Proliferation030304 developmental biologyMemory DisordersDentate gyrusfluoxetineFactor Mifbiological factorsRatsDisease Models AnimalAcoustic StimulationBromodeoxyuridineMacrophage migration inhibitory factorCorticosteroneNeuroscience030217 neurology & neurosurgery
researchProduct

Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery?

2019

Source at http://dx.doi.org/10.3748/wjg.v25.i3.388. BACKGROUND - The clinical presentation of gastroesophageal reflux disease (GERD) shows a large symptom variation also in different intensities among patients. As several studies have shown, there is a large overlap in the symptomatic spectrum between proven GERD and other disorders such as dyspepsia, functional heartburn and/or somatoform disorders. AIM - To prospectively evaluate the GERD patients with and without somatoform disorders before and after laparoscopic antireflux surgery. METHODS - In a tertiary referral center for foregut surgery over a period of 3 years patients with GERD, qualifying for the indication of laparoscopic antire…

AdultMalemedicine.medical_specialtyPsychometricsFundoplicationDiseaseLaparoscopic fundoplicationGastroesophageal reflux disease03 medical and health sciencesYoung Adult0302 clinical medicineQuality of lifeInternal medicineVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Gastroscopic surgery: 781medicineHumansddc:610Prospective StudiesYoung adultAntireflux surgeryLaparoscopyProspective cohort studySomatoform DisordersVDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gasteroenterologisk kirurgi: 781AgedAged 80 and overmedicine.diagnostic_testbusiness.industryGastroenterologyRefluxGeneral MedicineMiddle Agedmedicine.diseasehumanitiesdigestive system diseasesTreatment OutcomeSomatization030220 oncology & carcinogenesisGERDGastroesophageal RefluxQuality of LifeProspective Study030211 gastroenterology & hepatologyFemaleLaparoscopybusinessSomatizationGastroesophageal reflux disease symptomsWorld Journal of Gastroenterology
researchProduct

Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes

2003

Vulnivaccine, a vaccine against vibriosis caused by Vibrio vulnificus serovar E (formerly biotype 2), confers acceptable levels of protection to eels after its administration by prolonged immersion in three doses. Recently, a new pathogenic serovar, named serovar A, has been isolated from vaccinated eels in a Spanish freshwater eel farm. The main objective of this work was to design a bivalent vaccine, and to study its effectiveness against the two pathogenic serovars. With this aim, eels weighing around 20 g were immunised with the bivalent vaccine by oral and anal intubation, intraperitoneal injection (i.p.) and prolonged immersion. The overall results indicated that: (i) the new vaccine …

Serotypeanimal structuresmedicine.medical_treatmentIntraperitoneal injectionVibrio vulnificusAquatic ScienceMicrobiologyFish DiseasesImmune systemImmersionmedicineAnimalsEnvironmental ChemistryIntubation GastrointestinalVibrio vulnificusbiologyGeneral MedicineAnguillabiology.organism_classificationAntibodies BacterialMucusVirologyVaccinationKineticsSpainVibrio InfectionsBacterial VaccinesHumoral immunitybiology.proteinAntibodyInjections IntraperitonealFish & Shellfish Immunology
researchProduct

Development and Validation of the Adolescent and Children in Risk of Abuse and Maltreatment Protective Factors Scale (ACRAM-PFS)

2022

AbstractBackgroundChild maltreatment is a significant global problem concerning over 25% of children around the world. Traditionally, the assessment of children’s welfare was characterized by the creation of instruments and models from the deficit-based theoretical framework.PurposeThis study aims to develop an instrument to measure protective factors (the Adolescent and Children Risk of Abuse and Maltreatment Protective Factors Scale, ACRAM-PFS) and gather evidence on its psychometric properties. ACRAM-PFS is an 18-items scale for the assessment of protective factors of child maltreatment developed from the socioecological framework.MethodStructural validity, reliability and convergent-rel…

child welfareassessmentUNESCO::SOCIOLOGÍAprotective factorsGeneral Social Scienceschild maltreatmentSocial Sciences (miscellaneous)
researchProduct

Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage

2005

After SAH, primary and secondary complications are frequent and often require neurosurgical interventions to avoid secondary brain damage. The authors of the present paper have summarized the available data about the treatment modalities often used for patients with SAH. The present recommendations have been developed as a neurosurgical and neuroanestesiological consensus. Evidence from prospective, randomized, double blind, placebo-controlled studies support grade A recommendations (standard) for the prophylaxis and treatment of cerebral vasospasm with oral Nimodipine in good grade patients. For intravenous Nimodipine or for oral nimodipine treatment in poor grade patients, available data …

medicine.medical_specialtySubarachnoid hemorrhagemedicine.medical_treatmentNeurosurgeryBrain damageCerebral vasospasmGermanyAngioplastyHypovolemiaHumansVasospasm IntracranialMedicineProspective cohort studyNimodipineRandomized Controlled Trials as Topicbusiness.industrySubarachnoid Hemorrhagemedicine.diseaseSurgeryAnesthesiaSurgeryNeurology (clinical)medicine.symptombusinessHypervolemiaAngioplasty Balloonmedicine.drugNeurochirurgie
researchProduct

Monochorionic twin pregnancy: screening, pathogenesis of complications and management in the era of microinvasive fetal surgery

2010

Objective The management of monochorionic (MC) twin pregnancies varies in different medical centers. This paper compares screening methods to predict the complications of the MC twin pregnancy and different treatment methods. Methods We performed a literature search without language restriction in Cochrane library and PubMed (1970-2009). Case series and cohort screening studies, pathogenesis and management of complications of MC pregnancy were included. Results Elevated risk for intrauterine fetal death (IUFD) and twin-to-twin transfusion syndrome (TTTS) can be detected sonographically. Monitoring of MC pregnancies at increased risk and regular training sessions for the operating team combi…

Malemedicine.medical_specialtymedicine.medical_treatmentPrenatal diagnosisModels BiologicalPregnancyPrenatal DiagnosismedicineHumansAmnionNeonatologySurvival rateTwin PregnancyUltrasonographyFetal TherapiesPregnancyFetal Growth RetardationLaser CoagulationFetal surgeryObstetricsbusiness.industryInfant NewbornObstetrics and GynecologyChorionFetofetal TransfusionTwins Monozygoticmedicine.diseasePregnancy ComplicationsPediatrics Perinatology and Child HealthFemaleMonochorionic twinsPregnancy MultiplebusinessLaser coagulationJournal of Perinatal Medicine
researchProduct

Cytoprotective effect of resveratrol diastereomers in CHO-K1 cells exposed to beauvericin

2015

Beauvericin (BEA) causes cytotoxicity, lipid peroxidation and reactive oxygen species in CHO-K1 cells. Resveratrol (RSV) is a polyphenol with multiple biological properties, including antioxidant effects. RSV has two forms: trans and cis. The aims of this study were to determine the cytoprotective effect of trans-RSV and diastereomers mixtures (50:50 trans/cis-RSV and 70:30 trans/cis-RSV) incubated alone and in combination with BEA in ovarian (CHO-K1) cells. The results demonstrated that cell viability increases (from 9% to 77%) when they were exposed to low concentration of RSV. Moreover, when the cells were pre-treated with RSV and then exposed to BEA, a cytoprotective effect (from 25% to…

Antioxidantvirusesmedicine.medical_treatmentCHO CellsResveratrolToxicologymedicine.disease_causeLipid peroxidationchemistry.chemical_compoundCricetulusCricetinaeDepsipeptidesStilbenesmedicineAnimalsViability assayCytotoxicitychemistry.chemical_classificationReactive oxygen speciesChemistryvirus diseasesGeneral Medicinerespiratory systemMolecular biologyBeauvericinBiochemistryCytoprotectionResveratrolLipid PeroxidationReactive Oxygen SpeciesOxidative stressFood ScienceFood and Chemical Toxicology
researchProduct

Executive dysfunction in children affected by obstructive sleep apnea syndrome: an observational study

2013

Maria Esposito,1 Lorenzo Antinolfi,1 Beatrice Gallai,2 Lucia Parisi,3 Michele Roccella,3 Rosa Marotta,4 Serena Marianna Lavano,4 Giovanni Mazzotta,5 Francesco Precenzano,1 Marco Carotenuto1 1Sleep Clinic for Developmental Age, Clinic of Child and Adolescent Neuropsychiatry, Department of Mental and Physical Health and Preventive Medicine, Second University of Naples, Naples, Italy; 2Unit of Child and Adolescent Neuropsychiatry, University of Perugia, Perugia, Italy; 3Child Neuropsychiatry, Department of Psychology, University of Palermo, Palermo, Italy; 4Department of Psychiatry, Magna Graecia University of Catanzaro, Catanzaro, Italy; 5Unit of Child and Adolescent Neuropsychiatry, AUSL Umb…

Pediatricsmedicine.medical_specialtyNeuropsychiatric Disease and TreatmentNeurosciences. Biological psychiatry. NeuropsychiatryPolysomnographysleepinessOSAS polysomnography executive functions sleep sleepiness childrenpolysomnographychildrenmedicinesleepRC346-429Biological PsychiatryOriginal Researchmedicine.diagnostic_testIntelligence quotientbusiness.industryNeuropsychologyOSASexecutive functionsExecutive functionsmedicine.diseaseSettore MED/39 - Neuropsichiatria InfantileObstructive sleep apneaPsychiatry and Mental healthPopulation studyNeurology. Diseases of the nervous systembusinessBody mass indexRC321-571Executive dysfunction
researchProduct